Regencell Bioscience Holdings Limited
General ticker "RGC" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $10.6B (TTM average)
Regencell Bioscience Holdings Limited does not follow the US Stock Market performance with the rate: -25.5%.
Estimated limits based on current volatility of 10.5%: low 8.23$, high 10.15$
Factors to consider:
- Earnings expected soon, date: 2026-10-28 bmo
- Total employees count: 10 (-16.7%) as of 2025
Short-term RGC quotes
Long-term RGC plot
Financial data
| YTD | 2024-06-30 | 2025-06-30 | 2026-06-30 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $4.74MM | $3.77MM | $11.72MM |
| Operating Income | $-4.74MM | $-3.77MM | $-11.72MM |
| Non-Operating Income | $0.37MM | $0.19MM | $0.02MM |
| R&D Expense | $1.07MM | $0.95MM | $1.30MM |
| Income(Loss) | $-4.36MM | $-3.58MM | $-11.70MM |
| Net Income(Loss)* | $-4.30MM | $-3.58MM | $-11.70MM |
| Stockholders Equity | $8.22MM | $4.86MM | $13.35MM |
| Assets | $8.44MM | $5.76MM | $14.73MM |
| Operating Cash Flow | $-4.00MM | $-3.11MM | $-7.70MM |
| Capital expenditure | $0.01MM | $0.15MM | $0.00MM |
| Investing Cash Flow | $5.24MM | $2.69MM | $2.50MM |
| Financing Cash Flow | $0.10MM | $0.00MM | $16.95MM |
| Earnings Per Share** | $-0.01 | $-0.01 | $-0.02 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.